Regulatory & Legal

A new study reveals a tissue allograft, AmchoPlast™, triples healing rates for diabetic foot ulcers, offering a major breakthrough for a common complication.

From crypto pivots to robotics rallies, companies are making bold moves. But as narratives shift, discerning hype from reality is more crucial than ever.

DPL hires Brad Mendenhall to expand its platform as RIAs increasingly embrace commission-free insurance for holistic, fiduciary-first financial planning.

A music legend's donation fuels a new model for equitable recovery, helping Black communities in LA rebuild not just homes, but generational wealth.

New data shows Vyriad's VV169 eliminated myeloma in mice without severe toxicity, signaling a potential shift to safer, scalable 'off-the-shelf' CAR T.

Amid rising food insecurity, US Foods delivered nearly $12.5M in aid, powered by a 70% surge in employee volunteerism and new strategic programs.

Princess Cruises will air every FIFA World Cup match at sea. Is this a strategic play to win over sports fans and dominate the luxury travel market?

Keyfactor's new server on AWS aims to give each AI agent a unique digital identity, pioneering a new era of security for autonomous systems.

A revolutionary, non-toxic wood treatment is entering the market, promising to make homes safer from wildfires and disrupt a billion-dollar industry.

The Nasdaq-listed restaurant operator confirms its board and auditor, signaling stability as it navigates a volatile stock performance and dynamic F&B sector.

A major foundation is investing $75.8M to build a responsible public architecture for AI, funding projects that prioritize human rights and global equity.

Following a major legal victory in Peru, American Lithium will spin out its massive Macusani uranium project to capitalize on a surging nuclear energy market.

Pfizer projects lower 2026 earnings as COVID sales wane and patents expire, shifting focus to a multi-billion dollar R&D push for future growth.

Falco Resources restructures key debt and names a new board chair, gaining critical runway to advance its massive Horne 5 gold project in Quebec.

A new partnership between Beacon Biosignals and Harmony Biosciences will use AI to objectively measure sleepiness, offering new hope for hypersomnia patients.

After bombshell allegations and a stock plunge, Rezolve AI faces a major lawsuit investigation, raising critical questions about AI hype and corporate honesty.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

Kodiak Sciences is raising crucial capital with a stock offering, diluting investors but fueling its late-stage retinal drugs. Is this a necessary lifeline or a red flag?

Tiziana's CEO doubles down with a major share purchase, signaling deep faith in a novel MS drug, even as market signals send mixed messages.

A new report forecasts modest 2.6% growth for US construction in 2026, driven by data centers, water, and aviation, but challenged by major hurdles.